Varian places RT units; offers storage system

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 18 No 2
Volume 18
Issue 2

Varian Medical Systems, of Palo Alto, Calif., has installed new radiotherapy units at multiple sites worldwide:

Varian Medical Systems, of Palo Alto, Calif., has installed new radiotherapy units at multiple sites worldwide:

• Novalis Tx image-guided stereotactic body radiation therapy and radiosurgery platform at Oregon Health & Science University in Portland.

• Novalis Tx radiosurgery platform at Tata Memorial Hospital in Mumbai, India.

• RapidArc radiotherapy systems at Innovative Cancer Institute in South Miami, Fla., at Trinitas Comprehensive Cancer Center in Elizabeth, N.J., and at Sudharz Krankenhaus in Nordhausen, Germany.

• Clinac DHX at North Estonia Regional Hospital in Tallinn, Estonia.

In other news, at RSNA 2008 in Chicago, Varian released OncoView, an oncology-specific image management and storage system. OncoView is designed to supplement a hospital’s existing PACS.

Recent Videos
Once a patient-specific dose is determined, an all-oral combination of revumenib plus decitabine/cedazuridine and venetoclax may be “very good” in AML.
Patients with lung cancer who achieve a complete response with neoadjuvant therapy may not experience additional benefit with adjuvant immunotherapy.
Numerous trials have displayed the evolution of EGFR inhibition alone or with chemotherapy/radiation in the EGFR-mutated lung cancer space.
2 experts are featured in this series.
Although high grade adverse effects are infrequent among patients undergoing treatment for SCLC, CRS and ICANS may occur in higher frequencies.
Two experts are featured in this series.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 67th Annual ASH Meeting in Orlando.
4 experts are featured in this series.
Based on a patient’s SCLC subtype, and Schlafen 11 status, patients will be randomly assigned to receive durvalumab alone or with a targeted therapy in the S2409 PRISM trial.
4 experts are featured in this series.
Related Content